FDA Pushes to Broaden Warnings On Anti-Depressants

Health & Fitness Article Directory, Get Free Reprint Articles and Health & Fitness Content for your site with
article directory
54866 *recent articles in 509 categories Last article added 11/15/07
 
Article Categories
 
Reviews
 
Site Menu
 
Site Search


 
ArticlePros.com » Health & Fitness » Neurological Disorders » FDA Pushes to Broaden Warnings On Anti-Depressants

  • Date: 2007-05-02
  • Author: Mark Ramirez
  • All articles by this author
  • Visit author's website
  • FDA Pushes to Broaden Warnings On Anti-Depressants


    Related Neurological Disorders Articles

         The FDA is urging that a new warning be placed on the labels of all anti-depressants warning of an increased risk of suicidal thoughts and behavior. The current warning label warns of a increase of suicidal thoughts and behavior in children 18 and younger, but the FDA says that the warning should be expanded to also include young adults from 18-24 years old. The FDA has said that the increase of suicidal thoughts and behavior is limited only to those 24 years and younger. Those taking the ant-depressants 65 and older actually show a decreased risk of suicidal thoughts and behavior. Dr. Steven Galson, the FDA’s drugs chief said, “Antidepressant medications benefit many patients, but it is important that doctors and patients are aware of the risks.” NBC chief science correspondent Robert Bazell explained that many psychiatrists believe that the first 2 weeks after a young adult begins taking the medication are the most critical. "What this warning says is to pay close attention to [young] people when they are starting on the medication, when there is a slight risk of suicide. They should be followed much more closely than they need to be later on," he explained. Although it is good that the FDA has required the label change, some believe that the warnings have been long overdue. According to MSNBC, “last month, a comprehensive analysis of antidepressants for children and teenagers found the benefits of treatment trump the small risk of increasing suicidal thoughts and behaviors in some patients. The Journal of the American Medical Association study also found that risk is lower than what the FDA identified in 2004, the year the agency warned the public about the risks of the drugs in children.” Visit this Consumer Advocacy website for more information on ordering from a Mexican pharmacies.

    More articles from this pro: http://www.ArticlePros.com/author.php?Mark Ramirez


    More on Health & Fitness and Neurological Disorders can be found here.
     

    Get this article to go

    RSS | JScript | Email | HTML

     

    About the author

    Mark has been in the pharmaceutical search industry since 1999 and has quickly become one of the most widely used pharmaceutical resource sites. Visit this Consumer Advocacy website for more information on ordering from an online <a href="http://www.premiermexicanpharmacies.com">Mexican pharmacy</a>.

    http://www.premiermexicanpharmacies.com

     
    Email options
       

    ** Check all that apply **

     

    This article has been accessed 162 times since 2007-05-02.


    Home  •  Search  •  Add Your Own Article  •  RSS feeds  •  JavaScript Feeds  •   •  Set as Homepage  •  Add to Favourites
    Disclaimer: The information presented and opinions expressed herein are those of the authors
    and do not necessarily represent the views of ArticlePros.com and/or its partners.
    Copyright ArticlePros.com © 2005. All Rights Reserved